Mental health: A focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes

被引:97
作者
Blashill A.J. [1 ,2 ]
Perry N. [3 ]
Safren S.A. [1 ,2 ]
机构
[1] Massachusetts General Hospital, Harvard Medical School, Psychiatry/Behavioral Medicine Service, Boston, MA 02114
[2] Fenway Institute, Fenway Community Health, Boston, MA
[3] Massachusetts General Hospital, Psychiatry/Behavioral Medicine Service, Boston, MA 02114
关键词
CD4; Coping; Disease progression; HAART adherence; Health behaviors; Health care utilization; Health outcomes; HIV/AIDS; Mental illness; Stress; Treatment retention; Viral load;
D O I
10.1007/s11904-011-0089-1
中图分类号
学科分类号
摘要
Mental health problems are prevalent among HIV-infected individuals, with some estimates that 50% likely meet criteria for one or more psychiatric disorders. The mental health of HIV-infected individuals is important not only for quality-of-life concerns, but also in regard to HAART adherence and biological disease progression. The current review focuses on research published between 2009 and April of 2011, exploring mental health, coping, and stress in relation to HIV care behaviors including HAART adherence, quality of life, treatment retention, health care utilization, and disease progression amongst HIV-infected individuals. Specifically, we reviewed the most prevalent and interfering concerns among HIV-infected individuals-depression, post-traumatic stress disorder, interpersonal violence, stigma and shame, and body image concerns. Despite advances over the last 2 years documenting the deleterious effects of mental health on important HIV self-care behaviors, there is continued need for developing and disseminating evidence-based psychosocial interventions that integrate treating mental health problems with improving self-care behaviors for those living with HIV. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:215 / 222
页数:7
相关论文
共 60 条
[1]  
Bing E.G., Burnam M.A., Longshore D., Fleishman J.A., Sherbourne C.D., London A.S., Turner B.J., Eggan F., Beckman R., Vitiello B., Morton S.C., Orlando M., Bozzette S.A., Ortiz-Barron L., Shapiro M., Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States, Archives of General Psychiatry, 58, 8, pp. 721-728, (2001)
[2]  
Sherbourne C.D., Hays R.D., Fleishman J.A., Vitiello B., Magruder K.M., Bing E.G., McCaffrey D., Burnam A., Longshore D., Eggan F., Bozzette S.A., Shapiro M.F., Impact of psychiatric conditions on health-related quality of life in persons with HIV infection, American Journal of Psychiatry, 157, 2, pp. 248-254, (2000)
[3]  
HIV/AIDS Surveillance Report 2007
[4]  
Hall H.I., Song R., Rhodes P., Et al., Estimation of HIV incidence in the United States, JAMA, 300, pp. 520-529, (2008)
[5]  
Simoni J.M., Safren S.A., Manhart L.E., Et al., Challenges in addressing depression in HIV research: Assessment, cultural context, and methods, AIDS Behav, 15, pp. 376-388, (2011)
[6]  
Vosvick M., Martin L.A., Smith N.G., Et al., Gender differences in HIV-related coping and depression, AIDS Behav, 14, pp. 390-400, (2010)
[7]  
Orban L.A., Stein R., Koenig L.J., Et al., Coping strategies of adolescents living with HIV: Disease-specific stressors and responses, AIDS Care, 22, pp. 420-430, (2010)
[8]  
Ickovics J.R., Hamburger M.E., Vlahov D., Schoenbaum E.E., Schuman P., Boland R.J., Moore J., Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study, Journal of the American Medical Association, 285, 11, pp. 1466-1474, (2001)
[9]  
Leserman J., Role of depression, stress, and trauma in HIV disease progression, Psychosom. Med., 70, pp. 539-545, (2008)
[10]  
Nolen-Hoeksema S., Responses to depression and their effects on the duration of depressive episodes, J Abnorm Psychol, 100, pp. 569-582, (1991)